Sumanont Yaowared, Murakami Yukihisa, Tohda Michihisa, Vajragupta Opa, Watanabe Hiroshi, Matsumoto Kinzo
Division of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Biol Pharm Bull. 2007 Sep;30(9):1732-9. doi: 10.1248/bpb.30.1732.
This study aimed to investigate the mechanism underlying the protective effects of manganese complexes of curcumin (Cp-Mn) and diacetylcurcumin (DiAc-Cp-Mn) on kainic acid (KA)-induced excitotoxicity in the rat hippocampus. Systemic injection of KA (10 mg/kg, i.p.) caused seizures and increased the expression of neurotoxic markers, immediate early genes [c-jun, cyclooxygenase 2 (COX-2), brain-derived neurotrophic factor (BDNF), and heat shock protein 70 (hsp70)] and a delayed response gene [inducible nitric oxide synthase (iNOS)], which were measured at 6 and 72 h after KA injection, respectively, in the hippocampus. Pretreatment with Cp-Mn (50 mg/kg, i.p.) and DiAc-Cp-Mn (50 mg/kg, i.p.) but not with curcumin (50 mg/kg, i.p.) delayed the onset of KA-induced seizure without affecting the seizure score. KA injection induced c-Fos immunoreactivity in DG, CA1, and CA3 hippocampal regions, the expression of which peaked at 6 h after injection. Cp-Mn and DiAc-Cp-Mn treatment significantly decreased c-Fos expression elicited by KA. Moreover, Cp-Mn and DiAc-Cp-Mn administration suppressed the KA-induced expression of c-jun, COX-2, BDNF, and iNOS mRNA, whereas curcumin attenuated only iNOS mRNA expression. No compounds tested had an effect on KA-induced hsp70 expression. It is therefore likely that in addition to radical scavenging and SOD-like activities, the suppression of potential neuronal injury marker expression by Cp-Mn and DiAc-Cp-Mn, contributes to the neuroprotective activities of these compounds, which are superior to those of curcumin, on KA-induced excitotoxicity in the hippocampus. These results suggest the beneficial effects of Cp-Mn, and DiAc-Cp-Mn on the treatment of excitotoxicity-induced neurodegenerative diseases.
本研究旨在探讨姜黄素锰配合物(Cp-Mn)和双乙酰姜黄素锰配合物(DiAc-Cp-Mn)对大鼠海马中 kainic 酸(KA)诱导的兴奋性毒性的保护作用机制。全身注射 KA(10 mg/kg,腹腔注射)可引发癫痫发作,并增加神经毒性标志物、即刻早期基因[c-jun、环氧化酶 2(COX-2)、脑源性神经营养因子(BDNF)和热休克蛋白 70(hsp70)]以及一个延迟反应基因[诱导型一氧化氮合酶(iNOS)]的表达,分别在 KA 注射后 6 小时和 72 小时在海马中进行检测。用 Cp-Mn(50 mg/kg,腹腔注射)和 DiAc-Cp-Mn(50 mg/kg,腹腔注射)预处理可延迟 KA 诱导的癫痫发作起始,但不影响癫痫发作评分,而用姜黄素(50 mg/kg,腹腔注射)预处理则无此作用。KA 注射可诱导海马齿状回(DG)、CA1 和 CA3 区域的 c-Fos 免疫反应性,其表达在注射后 6 小时达到峰值。Cp-Mn 和 DiAc-Cp-Mn 处理可显著降低 KA 诱导的 c-Fos 表达。此外,Cp-Mn 和 DiAc-Cp-Mn 的给药可抑制 KA 诱导的 c-jun、COX-2、BDNF 和 iNOS mRNA 的表达,而姜黄素仅减弱 iNOS mRNA 的表达。所测试的化合物均对 KA 诱导的 hsp70 表达无影响。因此,除了自由基清除和类似超氧化物歧化酶(SOD)的活性外,Cp-Mn 和 DiAc-Cp-Mn 对潜在神经元损伤标志物表达的抑制作用可能有助于这些化合物在海马中对 KA 诱导的兴奋性毒性的神经保护活性,且这些活性优于姜黄素。这些结果表明 Cp-Mn 和 DiAc-Cp-Mn 对治疗兴奋性毒性诱导的神经退行性疾病具有有益作用。